Wearable Devices Ltd. held a special shareholder meeting where a quorum was reached after an adjournment and all seven proposals were approved. A key outcome was adoption of an amended and restated compensation policy for executives and directors.
The updated policy increases the chief executive officer’s maximum base salary and raises annual bonus caps. It also revises the mix between fixed and variable pay by role, expands equity-based compensation limits for office holders, and increases the maximum annual equity grants for directors. The detailed policy, dated September 2025, is attached as an exhibit and will govern salaries, bonuses, equity awards, change-of-control treatment and clawback mechanisms for the company’s office holders.
Wearable Devices Ltd. Schedule 13G shows Armistice Capital, LLC and Steven Boyd jointly report beneficial ownership of 619,818 ordinary shares, representing 9.99% of the class as of 12/31/2025. The shares are held directly by Armistice Capital Master Fund Ltd., for which Armistice Capital acts as investment manager and exercises voting and dispositive power under an Investment Management Agreement; the Master Fund disclaims beneficial ownership due to its inability to vote or dispose of the securities under that agreement. The joint filing is signed by Steven Boyd and dated 02/17/2026.
Wearable Devices Ltd. filed a Form 6-K highlighting a strategic product initiative and leadership appointment. The company plans to launch the Mudra Experience Studio, a developer platform that turns its neural input technology into a universal gesture language for extended reality (XR), mobile, desktop, and AI-powered applications.
The platform will offer production-ready SDKs, standardized gesture taxonomy, and integration with AI-driven development tools, aiming to let developers build once and deploy across Apple, Meta, Android XR, and desktop ecosystems. Wearable Devices opened a priority waitlist to support a 2026 rollout and reports strong early developer interest.
The company also appointed Ron Kaldes as Head of Growth, AI & Innovation to help drive the ai6 Labs and Mudra Experience Studio strategy, leveraging his background in consumer technology and AI consulting. The filing incorporates parts of this press release into existing S-8 and F-3 registration statements.
Wearable Devices Ltd. has launched ai6 Labs, a neural AI ecosystem designed to bridge human intent with digital reality using non-invasive Electromyography and its Mudra technology. The platform links foundational research, product commercialization, and rapid AI experimentation into a closed-loop system intended to accelerate innovation in touchless, intent-driven human–machine interaction.
The company positions ai6 Labs as a three-pillar ecosystem that turns biological signals into digital commands in a faster and more scalable way. Management describes this as an inflection point for AI wearables, extended reality gesture control, and non-invasive brain–computer interfaces, supporting its broader neural input product strategy.
Wearable Devices Ltd. appointed Kobbi Nir as an independent director to its Board of Directors. He is classified as a Class II director and is expected to be submitted for re-appointment at the company’s 2027 Annual General Meeting.
Mr. Nir will serve on the Board’s audit committee and compensation committee, bringing experience as CFO and deputy CEO of Moodify Ltd. and prior senior finance and board roles. He replaces Yaacov Goldman, who stepped down from the Board effective January 31, 2026, with the company stating his resignation was not due to any disagreement over operations, policies, or practices.
Wearable Devices Ltd., a foreign private issuer, submitted a Form 6-K to furnish the Notice of Meeting, Proxy Statement and Proxy Card for its Annual and Special General Meeting of Shareholders scheduled for October 24, 2025. Only shareholders of record holding ordinary shares at the close of business on September 26, 2024 are entitled to receive notice of, and vote at, the meeting in person or by proxy. The Form 6-K and its exhibit are also incorporated by reference into the company’s existing registration statements on Form S-8 and Form F-3.
Wearable Devices Ltd. entered a Securities Purchase Agreement with a single institutional investor for a combined equity and warrant financing. The company is selling 440,000 ordinary shares at $4.00 per share and pre-funded warrants for up to 560,000 ordinary shares at $3.9999 each in a registered direct offering. Each pre-funded warrant is immediately exercisable for one ordinary share at an exercise price of $0.0001, subject to a 9.99% beneficial ownership cap.
In a concurrent private placement, the investor will receive ordinary warrants to purchase up to 1,000,000 ordinary shares, exercisable immediately at $4.00 per share and expiring five years after issuance. The company engaged A.G.P./Alliance Global Partners as exclusive placement agent, agreeing to pay a 7.0% placement fee and a 1.0% management fee on aggregate gross proceeds, plus up to $65,000 for expenses. A related press release describes the transaction as a $4 million registered direct offering and concurrent private placement.
Wearable Devices Ltd. reported that it has secured a U.S. patent for a voice and gesture control technology aimed at AI-enabled wearables. The company announced the patent in a press release dated September 10, 2025, and the filing lists the press release as an exhibit to its current report. The report is signed by Asher Dahan, Chief Executive Officer. This disclosure is limited to the patent grant announcement; no financial metrics, transaction terms, or operational milestones were provided in the filing.
Wearable Devices Ltd. filed a Form S-8 to register securities under its 2024 Global Equity Incentive Plan, incorporating the plan by reference to a prior Form 6-K filed on August 22, 2024. The filing lists standard exhibits and professional consents from its independent auditor and counsel, and includes a limited indemnification framework for officers and directors covering certain litigation and administrative procedure expenses. The document is signed by the CEO, CFO and multiple directors on September 10, 2025.
Wearable Devices Ltd. reports that its board approved a significant increase in the ordinary shares reserved for its 2024 Global Equity Incentive Plan, adding 653,760 shares and raising the reserve from 141,492 to 795,252. This expands the pool available for future equity-based compensation grants.
The company also furnishes unaudited interim condensed consolidated financial statements and management’s discussion and analysis for the six months ended June 30, 2025, together with a press release on its first-half 2025 financial results. The report is incorporated by reference into existing Form S-8 and Form F-3 registration statements.